• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC141200J
Device Problem Unintended Movement (3026)
Patient Problem Aneurysm (1708)
Event Date 03/01/2020
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use, adverse events with may occur and/or require intervention including, but not limited to, endoleak.
 
Event Description
Following was reported to gore.On (b)(6) 2016, a patient underwent endovascular treatment of an abdominal aortic aneurysm using a gore® excluder® aaa endoprosthesis.On an unknown date, follow up imaging revealed a type ii endoleak from the inferior mesenteric artery (ima), but no aneurysm enlargement was observed; hence it was monitored.In (b)(6) 2020, follow up imaging revealed a continuous type ii endoleak and more than 5mm aneurysm enlargement.Additionally, a type iii endoleak (component disconnection) between contralateral leg components (pxc141200j and pxc141400j) that was placed on the left side was suspected.On (b)(6) 2020, a reintervention was performed.An additional stent graft was placed for treatment of the type iii endoleak, and coil embolization of the ima was performed.During the reintervention, there was no distal type i endoleak but an additional stent graft was placed prophylactically at the right side.The patient tolerated the procedure.
 
Manufacturer Narrative
B3: date of event - corrected to (b)(6) 2020.The actual date of the event is unknown, but reintervention occurred at some time in that month, so this has been chosen as the date of event.H10/11: narrative/corrected data -additional device involved in this event: pxc141400j, lot number 14510162, udi (b)(4), (b)(4), (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10214797
MDR Text Key201204386
Report Number2953161-2020-00023
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2018
Device Catalogue NumberPXC141200J
Device Lot Number14380196
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-